CIK 0001703057
- Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 604-559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- Open-market buys, last 90 days
- $1,366,800
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,366,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-01 | Hansen Carl L. G. Chief Executive Officer | Grant or award · Share option (right to buy) | +2,106,505 | 13,096,837 | ||
| 2025-01-01 | Hansen Carl L. G. Chief Executive Officer | Grant or award · Share option (right to buy) | +2,730,109 | 10,990,332 | ||
| 2024-11-25 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion | +56,125 | $2.70 | $152K | 898,000 |
| 2024-11-25 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion · Share option (right to buy) | −56,125 | 8,260,223 | ||
| 2024-09-20 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion | +56,125 | $2.70 | $152K | 841,875 |
| 2024-09-20 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion · Share option (right to buy) | −56,125 | 8,316,348 | ||
| 2024-05-31 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion | +56,125 | $2.70 | $152K | 785,750 |
| 2024-05-31 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion · Share option (right to buy) | −56,125 | 8,372,473 | ||
| 2024-02-26 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion | +56,125 | $2.70 | $152K | 729,625 |
| 2024-02-26 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion · Share option (right to buy) | −56,125 | 8,428,598 | ||
| 2024-01-14 | Hansen Carl L. G. Chief Executive Officer | Grant or award · Share option (right to buy) | +2,095,532 | 8,484,723 | ||
| 2023-11-23 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion | +56,125 | $2.70 | $152K | 673,500 |
| 2023-11-23 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion · Share option (right to buy) | −56,125 | 6,389,191 | ||
| 2023-08-24 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion | +56,125 | $2.70 | $152K | 617,375 |
| 2023-08-24 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion · Share option (right to buy) | −56,125 | 6,445,316 | ||
| 2023-05-26 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion | +56,125 | $2.70 | $152K | 561,250 |
| 2023-05-26 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion · Share option (right to buy) | −56,125 | 6,501,441 | ||
| 2023-02-22 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion | +56,125 | $2.70 | $152K | 505,125 |
| 2023-02-22 | Hansen Carl L. G. Chief Executive Officer | Exercise or conversion · Share option (right to buy) | −56,125 | 6,557,566 | ||
| 2022-12-01 | Hansen Carl L. G. Chief Executive Officer | Grant or award · Share Options (right to buy) | +925,069 | 6,613,691 |
Page 1 of 2 · 33 trades